The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study
Open accessAbstract
BACKGROUND: Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) but induce adverse events. OBJECTIVES: To evaluate the efficacy and safety of first-line tocilizumab in PMR. METHODS: In a prospective open-label study (ClinicalTrials.gov: NCT01713842), 20 glucocorticoid-free patients fulfilling Chuang's PMR criteria, with symptom onset within the last 12 months and a PMR activity score (PMR-AS) >10, each received three tocilizumab infusions at 4-week intervals, without glucocorticoids, followed by oral prednisone from weeks 12 to 24 (0.15 mg/kg if PMR-AS ≤10 and 0.30 mg/kg otherwise). The primary end point was the proportion of patients with PMR-AS≤10 at week 12. RESULTS: Baseline median PMR-AS was 36.6 (IQR 30.4-43.8). At week 12, all patients had PMR-AS≤10 and received the low prednisone dosage. Median PMR-AS at weeks 12 and 24 was 4.5 (3.2-6.8) and 0.95 (IQR 0.4-2), respectively (p<0.001 vs baseline for both time points). No patient required rescue treatment. Positron emission tomography-CT showed significant improvements. The most common adverse events were transient neutropenia (n=3) and leucopenia (n=5); in one patient, the second tocilizumab infusion was omitted due to leucopenia. CONCLUSIONS: Tocilizumab monotherapy is effective in recent-onset PMR. Randomised controlled trials are warranted. TRIAL REGISTRATION NUMBER: NCT01713842.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TCZ is also effective and safe for PMR treatment.114,115”
From Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: Review of the literature and personalized risk-based prevention strategy (2020) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dasgupta, B., Cimmino, M. A., Kremers, H. M., Schmidt, W., Schirmer, M., Salvarani, C., Bachta, A., Dejaco, C., Duftner, C., Jensen, H. S., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200329 · Cited by 676
Chuang, T., HUNDER, G. G., ILSTRUP, D. M., & KURLAND, L. T. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-5-672 · Cited by 527
HUSKISSON, E. C., & HART, F. D. (1987) · Elsevier eBooks · doi:10.1016/b978-0-7236-0571-3.50187-7 · Cited by 436
Dejaco, C., Singh, Y. P., Perel, P., Hutchings, A., Camellino, D., Mackie, S. L., Abril, A., Bachta, A., Balint, P. V., Barraclough, K., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207492 · Cited by 334
Dejaco, C., Singh, Y. P., Perel, P., Hutchings, A., Camellino, D., Mackie, S. L., Abril, A., Bachta, A., Balint, P. V., Barraclough, K., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39333 · Cited by 312
Prednisone plus Methotrexate for Polymyalgia Rheumatica
Caporali, R. F., Cimmino, M. A., Ferraccioli, G., Gerli, R., Klersy, C., Salvarani, C., Montecucco, C., & for the Systemic Vasculitis Study Group of the Italian Society for Rheumatology (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-7-200410050-00005 · Cited by 260
BSR and BHPR guidelines for the management of polymyalgia rheumatica
Dasgupta, B., Borg, F., Hassan, N., Barraclough, K., Bourke, B., Fulcher, J., Hollywood, J., Hutchings, A., Kyle, V., Nott, J., et al. (2009) · Rheumatology · doi:10.1093/rheumatology/kep303a · Cited by 249
A disease activity score for polymyalgia rheumatica
Leeb, B. F., & Bird, H. A. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011379 · Cited by 193
Carmona, F. D., Mackie, S. L., Martín, J., Taylor, J., Vaglio, A., Eyre, S., Bossini‐Castillo, L., Castañeda, S., Cid, M. C., Hernández‐Rodríguez, J., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.02.009 · Cited by 180
Dejaco, C., Singh, Y. P., Perel, P., Hutchings, A., Camellino, D., Mackie, S. L., Matteson, E. L., & Dasgupta, B. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207578 · Cited by 102
Cited by
Sorted by citations
Translating IL-6 biology into effective treatments
Choy, E., Benedetti, F. D., Takeuchi, T., Hashizume, M., John, M. R., & Kishimoto, T. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0419-z · Cited by 680
Interleukin (IL-6) ImmunotherapyPreprint
Tanaka, T., Narazaki, M., & Kishimoto, T. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028456 · Cited by 419
González-Gay, M. Á., Matteson, E. L., & Castañeda, S. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31825-1 · Cited by 264
Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities
Dejaco, C., Brouwer, E., Mason, J. C., Buttgereit, F., Matteson, E. L., & Dasgupta, B. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.142 · Cited by 225
Haanen, J., Ernstoff, M. S., Wang, Y., Menzies, A. M., Puzanov, I., Grivas, P., Larkin, J., Peters, S., Thompson, J. A., & Obeid, M. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.285 · Cited by 222
The Two-Faced Cytokine IL-6 in Host Defense and Diseases
Narazaki, M., & Kishimoto, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113528 · Cited by 214
Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry)
Pérez-De-Lis, M., Retamozo, S., Flores-Chávez, A., Kostov, B., Pérez-Álvarez, R., Brito‐Zerón, P., & Ramos‐Casals, M. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1372421 · Cited by 151
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper
Spiera, R., Unizony, S. H., Warrington, K. J., Sloane, J., Giannelou, A., Nivens, M. C., Akinlade, B. K., Wong, W., Bhore, R., Lin, Y., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2303452 · Cited by 138
Self-citationDevauchelle‐Pensec, V., Alegria, G. C., Dernis, E., Richez, C., Truchetet, M., Wendling, D., Toussirot, É., Perdriger, A., Gottenberg, J., Felten, R., et al. (2022) · JAMA · doi:10.1001/jama.2022.15459 · Cited by 135
Self-citationLally, L., Forbess, L. J., Hatzis, C., & Spiera, R. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39740 · Cited by 124
Bonelli, M. M., Radner, H., Kerschbaumer, A., Mrak, D., Durechova, M., Stieger, J., Husic, R., Mandl, P., Smolen, J. S., Dejaco, C., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221126 · Cited by 116
Espígol‐Frigolé, G., Dejaco, C., Mackie, S. L., Salvarani, C., Matteson, E. L., & Cid, M. C. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01310-7 · Cited by 102
Autoimmune manifestations associated with myelodysplastic syndromes
Grignano, É., Jachiet, V., Fenaux, P., Adès, L., Fain, O., & MEKINIAN, A. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3472-9 · Cited by 105
Yang, L., Guo, J., Yu, N., Liu, Y., Song, H., Niu, J., & Gu, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118487 · Cited by 94
Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica
Camellino, D., Matteson, E. L., Buttgereit, F., & Dejaco, C. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0458-5 · Cited by 84
Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis
van der Geest, K. S. M., Treglia, G., Glaudemans, A. W. J. M., Brouwer, E., Jamar, F., Slart, R. H. J. A., & Gheysens, O. S. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05162-6 · Cited by 85
Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica
Camellino, D., Giusti, A., Girasole, G., Bianchi, G., & Dejaco, C. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00705-5 · Cited by 76
Albrecht, K., Huscher, D., Buttgereit, F., Aringer, M., Hoese, G., Ochs, W., Thiele, K., & Zink, A. (2017) · Rheumatology International · doi:10.1007/s00296-017-3874-3 · Cited by 71
Unizony, S. H., McCulley, T. J., Spiera, R., Pei, J., Sidiropoulos, P. N. M., Best, J. H., Birchwood, C., Pavlov, A., & Stone, J. H. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02377-8 · Cited by 64
Gholamrezanezhad, A., Basques, K., Batouli, A., Matcuk, G. R., Alavi, A. A., & Jadvar, H. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.17.18523 · Cited by 63
Matteson, E. L., & Dejaco, C. (2017) · Annals of Internal Medicine · doi:10.7326/aitc201705020 · Cited by 60
Marsman, D. E., den Broeder, N., van den Hoogen, F. H. J., den Broeder, A. A., & van der Maas, A. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00245-9 · Cited by 57
The pathophysiology of polymyalgia rheumatica, small pieces of a big puzzle
Alegria, G. C., Boukhlal, S., Cornec, D., & Devauchelle‐Pensec, V. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102670 · Cited by 53
Self-citationKeller, K. K., Mukhtyar, C. B., Nielsen, A., Hemmig, A. K., Mackie, S. L., Sattui, S. E., Hauge, E., Dua, A. B., Helliwell, T., Neill, L. M., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-225134 · Cited by 51
Self-citationKastrati, K., Aletaha, D., Burmester, G. R., Chwala, E., Dejaco, C., Dougados, M., McInnes, I. B., Ravelli, A., Sattar, N. A., Stamm, T., et al. (2022) · RMD Open · doi:10.1136/rmdopen-2022-002359 · Cited by 49
Wendling, D., Tabaa, O. A., Chevet, B., Fakih, O., Ghossan, R., Hecquet, S., Dernis, E., Maheu, E., Saraux, A., Besson, F. L., et al. (2024) · Joint Bone Spine · doi:10.1016/j.jbspin.2024.105730 · Cited by 46
Self-citationSakai, R., Kondo, T., Kurasawa, T., Nishi, E., Okuyama, A., Chino, K., Shibata, A., Okada, Y., Takei, H., Nagasawa, H., et al. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3752-0 · Cited by 46
Huwart, A., Garrigues, F., Jousse‐Joulin, S., Marhadour, T., Guellec, D., Cornec, D., Gouillou, M., Saraux, A., & Devauchelle‐Pensec, V. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1499-2 · Cited by 46
Self-citationSamson, M., Devilliers, H., Ly, K. H., Maurier, F., Bienvenu, B., Terrier, B., Charles, P., Guillevin, L., Besancenot, J.-F., Liozon, É., et al. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.06.008 · Cited by 44
Spiera, R., Unizony, S. H., Bao, M., Luder, Y., Han, J., Pavlov, A., & Stone, J. H. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2021.03.006 · Cited by 44
Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single‐center, open‐label study
Chino, K., Kondo, T., Sakai, R., Saito, S., Okada, Y., Shibata, A., Kurasawa, T., Okuyama, A., Takei, H., & Amano, K. (2019) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13723 · Cited by 42
Saraux, A., Hénaff, C. L., Dernis, E., Alegria, G. C., Tison, A., Quéré, B., Petit, H., Felten, R., Jousse‐Joulin, S., Guellec, D., et al. (2023) · The Lancet Rheumatology · doi:10.1016/s2665-9913(23)00246-1 · Cited by 40
Self-citationTocilizumab in isolated polymyalgia rheumatica: A systematic literature review
Akiyama, M., Kaneko, Y., & Takeuchi, T. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.12.005 · Cited by 40
van der Geest, K. S. M., Sandovici, M., Nienhuis, P. H., Slart, R. H. J. A., Heeringa, P., Brouwer, E., & Jiemy, W. F. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.902155 · Cited by 39
Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable
Devauchelle‐Pensec, V., Saraux, L., Berthelot, J. M., Bandt, M. D., Cornec, D., Guellec, D., Marhadour, T., Jousse‐Joulin, S., Gouillou, M., & Saraux, A. (2017) · Rheumatology · doi:10.1093/rheumatology/kex477 · Cited by 38
Self-citationAlegria, G. C., Devauchelle‐Pensec, V., Renaudineau, Y., Saraux, A., Pers, J., & Cornec, D. (2017) · Rheumatology · doi:10.1093/rheumatology/kex169 · Cited by 36
Self-citationTaylor, P. C., Feist, E., Pope, J. E., Nash, P. T., Sibilia, J., Caporali, R., & Balsa, A. (2024) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x241283340 · Cited by 33
Saraux, A., Alegria, G. C., Dernis, E., Roux, C. H., Richez, C., Tison, A., Quéré, B., Jousse‐Joulin, S., Guellec, D., Marhadour, T., et al. (2025) · The Lancet Rheumatology · doi:10.1016/s2665-9913(24)00270-4 · Cited by 33
Self-citationEfficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study
Zhang, L., Li, J., Yin, H., Chen, D., Li, Y., Gu, L., Fu, Y., Chen, J., Chen, Z., Yang, S., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223562 · Cited by 33
Polymyalgia rheumatica: An updated review
Mahmood, S. B., Nelson, E., Padniewski, J. J., & Nasr, R. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.20008 · Cited by 31
Laporte, J.-P., Garrigues, F., Huwart, A., Jousse‐Joulin, S., Marhadour, T., Guellec, D., Cornec, D., Devauchelle‐Pensec, V., & Saraux, A. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.180958 · Cited by 30
Self-citationNew insights into the role of imaging in polymyalgia rheumatica
Camellino, D., Duftner, C., & Dejaco, C. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa646 · Cited by 28
Treatment of polymyalgia rheumatica
Castañeda, S., García-Castañeda, N., Prieto-Pena, D., Martínez-Quintanilla, D., Vicente, E. F., Blanco, R., & González-Gay, M. Á. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.027 · Cited by 27
Polymyalgia rheumatica: an autoinflammatory disorder?
Floris, A., Piga, M., Cauli, A., Salvarani, C., & Mathieu, A. (2018) · RMD Open · doi:10.1136/rmdopen-2018-000694 · Cited by 25
Polymyalgia Rheumatica: a Common Disease in Seniors
Gazitt, T., Zisman, D., & Gardner, G. C. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00919-2 · Cited by 25
Marsman, D. E., Bolhuis, T. E., den Broeder, N., den Broeder, A. A., & van der Maas, A. (2022) · Trials · doi:10.1186/s13063-022-06263-3 · Cited by 24
Elderly-onset rheumatoid arthritis vs. polymyalgia rheumatica: Differences in pathogenesis
Wu, J., Yang, F., Ma, X., Lin, J., & Chen, W. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1083879 · Cited by 25
Current and emerging therapies in large-vessel vasculitis
Kermani, T. A., & Dasgupta, B. (2017) · Rheumatology · doi:10.1093/rheumatology/kex385 · Cited by 23
Izumi, K., Murata, O., Higashida‐Konishi, M., Kaneko, Y., Oshima, H., & Takeuchi, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132948 · Cited by 23
Genetically proxied IL-6 receptor inhibition and risk of polymyalgia rheumatica
Zhao, S. S., & Gill, D. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2022-222578 · Cited by 23
Assaraf, M., Chevet, B., Wendling, D., Philippe, P., Cailliau, É., Roux, C. H., Dieudé, P., Ottaviani, S., Avouac, J., Delacour, M., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/kead426 · Cited by 22
Self-citationHas the time come for biotherapies in giant cell arteritis and polymyalgia rheumatica?
Devauchelle‐Pensec, V. (2016) · Joint Bone Spine · doi:10.1016/j.jbspin.2016.07.003 · Cited by 20
Self-citationPolymyalgia rheumatica: An update (Review)
Florescu, M. M., BOBIRCA, F. T., Florescu, A., Pădureanu, V., Bobirca, A. V., Ciurea, P. L., Criveanu, C., Florescu, L. M., & Mușetescu, A. E. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12242 · Cited by 19
Era of steroid sparing in the management of immune-mediated inflammatory diseases
Kondo, T., & Amano, K. (2018) · Immunological Medicine · doi:10.1080/09114300.2018.1451593 · Cited by 19
Understanding the immunopathophysiology of polymyalgia rheumatica: implications for treatment
Choy, E., Unizony, S. H., Wells, A. F., Dasgupta, B., Buttgereit, F., & Tanaka, Y. (2025) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2025.09.005 · Cited by 18
Craig, G. L., Knapp, K. D., Salim, B. A., Mohan, S., & Michalska, M. (2021) · Rheumatology and Therapy · doi:10.1007/s40744-021-00290-3 · Cited by 17
Predicting the risk of relapse in polymyalgia rheumatica: novel insights
Prieto-Pena, D., Castañeda, S., Atienza‐Mateo, B., Blanco, R., & González-Gay, M. Á. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1890032 · Cited by 16
The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica
Venborg, J., Wegeberg, A., Kristensen, S., Brock, B., Brock, C., & Pfeiffer‐Jensen, M. (2021) · Pharmaceuticals · doi:10.3390/ph14111166 · Cited by 16
Camellino, D., Soldano, S., Cutolo, M., & Cimmino, M. A. (2018) · Rheumatology International · doi:10.1007/s00296-018-4086-1 · Cited by 16
Hattori, K., Hirano, Y., & Kojima, T. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13978 · Cited by 16
Kawka, L., Chevet, B., Arnaud, L., Becker, G., Alegria, G. C., & Felten, R. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103590 · Cited by 15
Recent advances in the diagnosis and treatment of polymyalgia rheumatica
Muratore, F., Pazzola, G., Pipitone, N., & Salvarani, C. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1178572 · Cited by 15
Efficacy of methotrexate in polymyalgia rheumatica in routine rheumatology clinical care
Ruediger, C. D., Nguyen, L., Black, R. J., Proudman, S., & Hill, C. L. (2020) · Internal Medicine Journal · doi:10.1111/imj.14779 · Cited by 15
Musculotendinous Inflammation: The Defining Pathology of Polymyalgia Rheumatica?
Owen, C., Liew, D. F. L., & Buchanan, R. R. C. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.190367 · Cited by 15
Buttgereit, F., & Tam, L. (2026) · The Lancet Rheumatology · doi:10.1016/s2665-9913(26)00072-x · Cited by 14
Ughi, N., Sebastiani, G. D., Gerli, R., Salvarani, C., Parisi, S., Ariani, A., Prevete, I., MANARA, M., Rumi, F., Scirè, C. A., et al. (2020) · Reumatismo · doi:10.4081/reumatismo.2020.1268 · Cited by 14
Toussirot, É., Régent, A., Devauchelle‐Pensec, V., Saraux, A., & Puéchal, X. (2016) · RMD Open · doi:10.1136/rmdopen-2016-000305 · Cited by 14
Self-citationTherapeutic response to prednisone in relation to age in polymyalgia rheumatica: a comparison study
Charpentier, A., Verhoeven, F., Sondag, M., Guillot, X., Prati, C., & Wendling, D. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-3988-3 · Cited by 13
Camellino, D., Dejaco, C., Buttgereit, F., & Matteson, E. L. (2019) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2019.07.005 · Cited by 13
Ponfilly, M. P. D., Séror, R., Nocturne, G., & Besson, F. L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1070445 · Cited by 12
Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica
Toussirot, É., Michaud, M., Wendling, D., & Devauchelle‐Pensec, V. (2021) · The Journal of Rheumatology · doi:10.3899/jrheum.210455 · Cited by 12
Self-citationMukhtyar, C. B., Nikiphorou, E., Bartoletti, A., Dey, M., Ducker, G., Misra, D. P., Monti, S., Studenic, P., Berti, A., Blockmans, D., et al. (2026) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2026.06.009 · Cited by 11
Satybaldyev, A. M., Demidova, N. V., Savushkina, N. M., & Gordeev, A. V. (2018) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2018-215-227 · Cited by 11
Alegria, G. C., Cornec, D., Renaudineau, Y., Saraux, A., & Devauchelle‐Pensec, V. (2021) · Rheumatology and Therapy · doi:10.1007/s40744-021-00299-8 · Cited by 11
Self-citationBolhuis, T. E., Bösch, P., Falzon, L., Owen, C., Yates, M. M., Mackie, S. L., van der Maas, A., & Dejaco, C. (2024) · Rheumatology · doi:10.1093/rheumatology/keae428 · Cited by 10
Hayashi, K., Ohashi, K., Watanabe, H., Sada, K., Shidahara, K., Asano, Y., Asano, S. H., Yamamura, Y., Miyawaki, Y., Morishita, M., et al. (2019) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x19864822 · Cited by 10
Tocilizumab controls bone turnover in early polymyalgia rheumatica
Alegria, G. C., Garrigues, F., Bettacchioli, É., Lœuille, D., Saraux, A., Cornec, D., Devauchelle‐Pensec, V., & Renaudineau, Y. (2020) · Joint Bone Spine · doi:10.1016/j.jbspin.2020.105117 · Cited by 10
Self-citationPseudo-polyarthrite rhizomélique et artérite à cellules géantes en 2019
Alegria, G. C., Guellec, D., Devauchelle‐Pensec, V., & Saraux, A. (2019) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2019.02.006 · Cited by 10
Self-citationManaging of giant cell arteritis and polymyalgia rheumatica
González-Gay, M. Á., & Castañeda, S. (2016) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1244480 · Cited by 9
Infection, Immunodeficiency, and Inflammatory Diseases in Autoimmune Neurology
Clardy, S. L., & Piquet, A. L. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1660820 · Cited by 9
Efficacy of JAK Inhibitors versus DMARDs in the Treatment of Polymyalgia Rheumatica in China
Gu, J., Yang, M., Zhang, B., & Wang, H. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s414267 · Cited by 8
Update on treatment of polymyalgia rheumatica
Camellino, D., & Dejaco, C. (2018) · Reumatismo · doi:10.4081/reumatismo.2018.1062 · Cited by 8
[18F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica
Allard, B., Devauchelle‐Pensec, V., Saraux, A., Nowak, E., Tison, A., Boukhlal, S., Guellec, D., Jousse‐Joulin, S., Cornec, D., Marhadour, T., et al. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06557-x · Cited by 7
Self-citationGarcı́a-Porrúa, C., Heras-Recuero, E., Blázquez-Sánchez, T., Torres-Roselló, A., Castañeda, S., & González-Gay, M. Á. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216492 · Cited by 7
Efficacy and Safety of Tocilizumab in Polymyalgia Rheumatica: A Systematic Review and Meta‐Analysis
Sharma, M., Das, S. K., Mohindra, R., & Dutta, D. (2025) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.70106 · Cited by 7
The frequency of occult solid malignancy in patients with polymyalgia rheumatica-like symptoms
Ramon, A., Guillibert-Karras, C., Milas-Julien, L., Garrot, J.-F., Maillefert, J.-F., & Ornetti, P. (2021) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x20984275 · Cited by 7
Measurement Properties of the Polymyalgia Rheumatica Activity Score: A Systematic Literature Review
Bolhuis, T. E., Nizet, L. E. A., Owen, C., den Broeder, A. A., van den Ende, C. H. M., & van der Maas, A. (2022) · The Journal of Rheumatology · doi:10.3899/jrheum.211292 · Cited by 7
Okazaki, S., Watanabe, R., Kondo, H., Kudo, M., Harigae, H., & Fujii, H. (2020) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.251.125 · Cited by 6
Desvages, A., Hives, F., Deprez, X., Piérache, A., Behal, H., Flipo, R., & Paccou, J. (2021) · Journal of Clinical Medicine · doi:10.2139/ssrn.3882520 · Cited by 6
Concordance and agreement between different activity scores in polymyalgia rheumatica
D'Agostino, J., Souki, A., Lohse, A., Alegria, G. C., Dernis, E., Richez, C., Truchetet, M., Wendling, D., Toussirot, É., Perdriger, A., et al. (2024) · RMD Open · doi:10.1136/rmdopen-2023-003741 · Cited by 6
Self-citationDrug therapies for polymyalgia rheumatica: a pharmacotherapeutic update
González-Gay, M. Á., Pina, T., Prieto-Pena, D., Calderón-Goercke, M., Blanco, R., & Castañeda, S. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1501360 · Cited by 6
Shiraishi, K., Masei, S. U. D. A., ROKUTANDA, R., KISHIMOTO, M., & OKADA, M. (2018) · Archives of Rheumatology · doi:10.5606/archrheumatol.2018.6418 · Cited by 6
Lally, L., & Spiera, R. (2018) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2019.04.006 · Cited by 6
Tocilizumab in recent polymyalgia rheumatica: how can we manage the interleukin-6 blockage?
Devauchelle‐Pensec, V., & Saraux, A. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209607 · Cited by 6
Self-citationIs Tocilizumab as efficient as steroids early in polymyalgia rheumatica?
Alegria, G. C., Saraux, A., & Devauchelle‐Pensec, V. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.04.013 · Cited by 6
Self-citationMadec, A. L., Querellou, S., Binard, A., Saraux, A., Quéré, B., Marhadour, T., Jousse‐Joulin, S., Tison, A., Cornec, D., Guellec, D., et al. (2025) · Joint Bone Spine · doi:10.1016/j.jbspin.2025.105950 · Cited by 5
Self-citationMethoden zur Erfassung der Krankheitsaktivität der Polymyalgia rheumatica
Reisch, M., & Dejaco, C. (2023) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-023-01358-x · Cited by 5
Steroid-sparing agents in polymyalgia rheumatica: how will they fit into the treatment paradigm?
Ricordi, C., Pipitone, N., Marvisi, C., Muratore, F., & Salvarani, C. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2240519 · Cited by 5
Prevention of bleomycin-induced pulmonary fibrosis by vaccination with the Tocilizumab mimotope
Guo, J., Yang, L., Song, H., & Bai, L. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2319965 · Cited by 5
Nasonov, E. L., Satybaldyev, A. M., Otteva, E. N., Beketova, T. V., & Baranov, A. A. (2024) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2024-348-364 · Cited by 5
Metadata
- Authors
- Devauchelle-Pensec, V., Berthelot, J. M., Cornec, D., Renaudineau, Y., Marhadour, T., Jousse-Joulin, S., Querellou, S., Garrigues, F., De Bandt, M., Gouillou, M., & Saraux, A.
- Affiliations
- Centre Hospitalier Universitaire de Nantes (FR)
- Université de Bretagne Occidentale (FR)
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 75
- Issue
- 8
- Pages
- 1506-1510
- ISSN
- 0003-4967 (ISSN-L)
- PMC
- PMC4975852
- OpenAlex
- W2290444582
- Cited by
- 171
- References
- 22
- Citations by year
- 2026: 15 · 2025: 10 · 2024: 18 · 2023: 19 · 2022: 19 · 2021: 17 · 2020: 19 · 2019: 11 · 2018: 18 · 2017: 16 · 2016: 8
- FWCI
- 15.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Annals of the Rheumatic Diseases (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Chugai Pharmaceutical
- Topics
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Otitis Media and Relapsing Polychondritis
- Keywords
- tocilizumab, polymyalgia rheumatica, steroid-sparing therapy, prednisone, IL-6 inhibition, neutropenia, leukopenia, treatment efficacy and safety
- MeSH terms
- Positron Emission Tomography Computed Tomography, Aged, Drug Administration Schedule, Drug Therapy, Combination, Female, Glucocorticoids, Humans, Infusions, Intravenous, Longitudinal Studies, Male, Middle Aged, Polymyalgia Rheumatica, Prednisone, Prospective Studies, Severity of Illness Index, Treatment Outcome, Antirheumatic Agents, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
